Skye Bioscience, Inc. (SKYE)

0.887 +0.14 (+18.31%) USD  |  NASDAQ  |  Jan 02, 16:00
0.887 0.00 (0.00%) After-Hours: 17:03
More

Skye Bioscience Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for SKYE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Perspective Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
FibroGen, Inc. Upgrade
Myomo, Inc. Upgrade